%0 Journal Article %1 Hogan2018 %A Hogan, Glenn %A Tangney, Mark %D 2018 %J Trends in pharmacological sciences %K R&D academia biotechnology businessandindustry pharmaceuticalindustry %N 10 %P 848-852 %R 10.1016/j.tips.2018.08.002 %T The Who, What, and Why of Drug Discovery and Development. %U https://linkinghub.elsevier.com/retrieve/pii/S0165614718301378 http://www.ncbi.nlm.nih.gov/pubmed/30196936 %V 39 %X Inquiry into declining pharmaceutical R&D efficiency has focussed on 'what' can be improved, with only brief thought given to 'who' can be improved. Here, we argue that enabling people in the idea-to-product chain to have a more holistic knowledge of the behaviours and incentives of each other can optimise R&D.

@article{Hogan2018, abstract = {Inquiry into declining pharmaceutical R&D efficiency has focussed on 'what' can be improved, with only brief thought given to 'who' can be improved. Here, we argue that enabling people in the idea-to-product chain to have a more holistic knowledge of the behaviours and incentives of each other can optimise R&D.}, added-at = {2023-02-03T11:44:35.000+0100}, author = {Hogan, Glenn and Tangney, Mark}, biburl = {https://www.bibsonomy.org/bibtex/240087eadaf442b97256fc7df2437e621/jepcastel}, doi = {10.1016/j.tips.2018.08.002}, interhash = {c399a25710479623fe38cccb41cbb39e}, intrahash = {40087eadaf442b97256fc7df2437e621}, issn = {1873-3735}, journal = {Trends in pharmacological sciences}, keywords = {R&D academia biotechnology businessandindustry pharmaceuticalindustry}, month = {10}, note = {Recerca clínica; Indústria}, number = 10, pages = {848-852}, pmid = {30196936}, timestamp = {2023-02-03T11:44:35.000+0100}, title = {The Who, What, and Why of Drug Discovery and Development.}, url = {https://linkinghub.elsevier.com/retrieve/pii/S0165614718301378 http://www.ncbi.nlm.nih.gov/pubmed/30196936}, volume = 39, year = 2018 }